722 related articles for article (PubMed ID: 31548041)
21. A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids.
Ghonim M; Magdy R; Sabbour M; Ghonim M; Nabhan A
Int J Gynaecol Obstet; 2019 Aug; 146(2):141-148. PubMed ID: 31127621
[TBL] [Abstract][Full Text] [Related]
22. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
Kitade M; Kumakiri J; Kobori H; Murakami K
Trials; 2024 May; 25(1):343. PubMed ID: 38790029
[TBL] [Abstract][Full Text] [Related]
24. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
25. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
Szamatowicz M; Kotarski J
Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
[TBL] [Abstract][Full Text] [Related]
26. A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids.
Van Voorhis B
JAMA; 2009 Jan; 301(1):82-93. PubMed ID: 19050179
[TBL] [Abstract][Full Text] [Related]
27. A systematic review of the psychosocial impact of fibroids before and after treatment.
Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH
Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012
[TBL] [Abstract][Full Text] [Related]
28. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
29. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
30. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
31. Role of Medical Management for Uterine Leiomyomas.
Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
[TBL] [Abstract][Full Text] [Related]
32. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Obstet Gynecol; 2021 Jun; 137(6):e100-e115. PubMed ID: 34011888
[TBL] [Abstract][Full Text] [Related]
33. Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial.
Osuga Y; Nakano Y; Yamauchi Y; Takanashi M
Fertil Steril; 2021 Jul; 116(1):189-197. PubMed ID: 33715871
[TBL] [Abstract][Full Text] [Related]
34. Uterine artery embolization for symptomatic uterine fibroids.
Gupta JK; Sinha A; Lumsden MA; Hickey M
Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of fibroids in heavy menstrual bleeding.
Saridogan E
Womens Health (Lond); 2016 Jan; 12(1):53-62. PubMed ID: 26693796
[TBL] [Abstract][Full Text] [Related]
36. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
[TBL] [Abstract][Full Text] [Related]
37. Ulipristal acetate versus placebo for fibroid treatment before surgery.
Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
[TBL] [Abstract][Full Text] [Related]
38. Uterine artery embolization for symptomatic uterine fibroids.
Gupta JK; Sinha AS; Lumsden MA; Hickey M
Cochrane Database Syst Rev; 2006 Jan; (1):CD005073. PubMed ID: 16437515
[TBL] [Abstract][Full Text] [Related]
39. Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids.
Lynch SE; Mayer DC
Ann Pharmacother; 2022 Jan; 56(1):93-101. PubMed ID: 33998300
[TBL] [Abstract][Full Text] [Related]
40. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE
Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
